Cargando…
Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels
Chemoresistance is a major problem in the therapeutic management of pancreatic cancer, concurring to poor clinical outcome. A number of mechanisms have been proposed to explain resistance to gemcitabine, a standard of care for this malignancy, among which is included aberrant miRNA expression. In th...
Autores principales: | Panebianco, Concetta, Trivieri, Nadia, Villani, Annacandida, Terracciano, Fulvia, Latiano, Tiziana Pia, Potenza, Adele, Perri, Francesco, Binda, Elena, Pazienza, Valerio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146031/ https://www.ncbi.nlm.nih.gov/pubmed/33925948 http://dx.doi.org/10.3390/biom11050639 |
Ejemplares similares
-
High Levels of Prebiotic Resistant Starch in Diet Modulate a Specific Pattern of miRNAs Expression Profile Associated to a Better Overall Survival in Pancreatic Cancer
por: Trivieri, Nadia, et al.
Publicado: (2020) -
Tuning gut microbiota through a probiotic blend in gemcitabine‐treated pancreatic cancer xenografted mice
por: Panebianco, Concetta, et al.
Publicado: (2021) -
Targeting Gut Microbiota in Cancer Cachexia: Towards New Treatment Options
por: Panebianco, Concetta, et al.
Publicado: (2023) -
Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRAS(G12D) mutated pancreatic cancer in vivo model
por: Panebianco, Concetta, et al.
Publicado: (2023) -
High Levels of Prebiotic Resistant Starch in Diet Modulate Gene Expression and Metabolomic Profile in Pancreatic Cancer Xenograft Mice
por: Panebianco, Concetta, et al.
Publicado: (2019)